Research and development (R&D) are the lifeblood of biotech companies, driving innovation and creating cutting-edge technologies for understanding the biological processes. These activities are crucial for developing novel therapies, diagnostic tools and biotechnological products that address a wide range of needs in the healthcare landscape. The success of biotech companies relies on their ability to effectively conduct R&D, which involves a combination of rigorous scientific exploration, technological advancements, and regulatory compliance. Prepare to embark on this incredible journey to explore the indispensable role of R&D as a driver of innovation in biotech companies, enabling the development of groundbreaking therapies and tools for advancing human health. In this week’s episode, we chatted with Rose Fida, PhD - She has extensive experience in the biotech field and currently working as Senior Director of R&D and head of China and Japan project management at CSL, a global biotechnology company. Tune in to learn more about her extraordinary research journey and tips for all the young and passionate students who want to create an impact in the R&D of the pharma or biotech sector.
0:01 Introduction
0:50 Dr. Fida self-introduction
1:23 Your LinkedIn profile has quite an impressive array of different degrees, was doing a PhD in medicine always your end-goal? And what was your thought process as you went through these different degrees?
4:50 Moving on to your role in CSL, how would you describe the importance and the nature of your role in research and development in the company, and your position as a leader of the team as well?
10:21 What challenges might you face in your current position?
12:29 Which drug project in particular has been dear to your heart during your time in this position?
14:59 With your management of the China and Japan branch, could you dive a bit into what kind of goals you have for the next 5 to 10 years, or decades, to come?
17:17 How do you find collaborating with the unique and different local healthcare systems in China and in Japan, and why do you it is important that we are branching out to other countries?
19:47 How do you think these processes (in context to the previous question) would differ to how things are done in Australia?
21:00 Did you choose to be involved in managing projects in China and Japan specifically, since CSL has so many locations around the world?
22:54 We know that the recent COVID-19 pandemic has impacted so many areas of our lives, and it has not only shifted the ways we work, but also the ways we interact and how we view our healthcare system as well, and as a consequence there has also been an increased awareness and demand for better healthcare products and procedures alike. So how would you say this has impacted your role, and have you seen any trends or changes emerge from this pandemic?
27:03 What are some advice or tips can you offer us uni students or graduates or even anyone in the field working as a scientist that might want to do research and development, or maybe even governance, in the future?
32:06 Conclusion
32:30 Acknowledgement of country
32:41 Outro
Visit our website to find all the platforms we're on!
https://doseofpharma.wordpress.com/
Riviera by Smith The Mister https://smiththemister.bandcamp.com
Smith The Mister https://bit.ly/Smith-The-Mister-YT
Free Download / Stream: https://bit.ly/al-riviera
Music promoted by Audio Library https://youtu.be/qonPqql2sP0